+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID07898683

Phase I Trial of Selective Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Adenocarcinoma Treatment

Led by National Medical Research Radiological Centre of the Ministry of Health of Russia · Updated on 2026-10-27

12

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Pancreatic adenocarcinoma is a very serious cancer with few treatment options for those whose tumors cannot be surgically removed. Researchers are evaluating the safety and tolerability of using Yttrium-90 90Y glass microspheres delivered directly into the arteries feeding the tumor to target radiation treatment. This Phase I clinical trial aims to assess radiation dose distribution, side effects, and early signs of how the tumor responds to this selective arterial radioembolization. Participants will first undergo imaging and dose planning using a special scan called SPECTCT with 99mTc-labeled macroaggregated albumin to understand how the microspheres will distribute. Then, the Yttrium-90 microspheres will be infused into the tumors arteries through a catheter, with doses gradually increased in small groups of patients. After treatment, further imaging and dosimetry tests will measure how the radiation was distributed and evaluate the tumors response. During the study, participants will be closely monitored for safety and side effects for up to 8 weeks after the procedure. Radiation exposure will be assessed immediately after treatment, and tumor response will be evaluated at 8 weeks. The total study participation may last until the final assessments are completed, with careful follow-up to understand the impact of the treatment and any adverse effects.

CONDITIONS

Brief Title

A Phase I Study of Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Cancer

Research Team

A

Artur Petrosian

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here